Walker, JJ. Pre-eclampsia. Lancet 2000; 356: 1260–5.Google Scholar

Main, EK, McCain, CL, Morton, CH, et al. Pregnancy related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol 2015; 125: 938–47.CrossRefGoogle ScholarPubMed

American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122(5): 1122–31.Google Scholar

National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1–22.Google Scholar

Rogers, LK, Velten, M. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease. Life Sci 2011; 89: 417–21.Google Scholar

Markham, KB, Funai, EF. Pregnancy-related hypertension. In Creasy, RK, Resnik, R, Iams, JD, et al., eds., Maternal-Fetal Medicine: Principles and Practice, 7th edn. Philadelphia: Saunders, 2014: 856–81.Google Scholar

American Congress of Obstetricians and Gynecologists (ACOG). Diagnosis and Management of Preeclampsia and Eclampsia (American Congress of Obstetricians and Gynecologists Practice Bulletin Number 33), ACOG, Washington, DC, 2002 (reaffirmed 2012).Google Scholar

Spong, CY, Mercer, BM, D’Alton, M, et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011; 118: 323–33.Google Scholar

Abalos, A, Duley, L, Steyn, DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014; 2: CD002252Google Scholar

Magee, L.A., Elran, E., Bull, S.B., et al: Risks and benefits of beta receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 2000; 88: 15–26.Google Scholar

Magee, LA, von Dadelszen, P, Rey, E, et al. The control of hypertension in pregnancy study (CHIPS) randomized controlled trial. Pregnancy Hypertens 2015; 5: 2.Google Scholar

Buchbinder, A, Sibai, BM, Caritis, S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186: 66–71.Google Scholar

Saudan, P, Brown, MA, Buddle, ML, et al. Does gestational hypertension become pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 1177–84.CrossRefGoogle ScholarPubMed

Wu, Y, Xiong, X, Fraser, WD, et al. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. Am J Hypertens 2012; 25: 711–17.Google Scholar

Sibai, BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163: 1049–54.Google Scholar

North, RA, Taylor, RS, Schellenberg, JC. Evaluation of a definition of preeclampsia. Br J Obstet Gynaecol 1999; 106: 767–73.Google Scholar

Woelkers, D, Barton, J, von Dadelszen, P, et al. Rates of adverse outcomes are elevated in preterm patients with suspected hypertensive disorders without diagnostic criteria for preeclampsia. Pregnancy Hypertens 2015; 5: 39.Google Scholar

Abalos, E, Cuesta, C, Grosso, AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013; 170: 1–7.CrossRefGoogle ScholarPubMed

Sibai, BM, Barton, JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007; 196: 514.e1–9.CrossRefGoogle ScholarPubMed

Sibai, BM. Pre-eclampsia. Lancet 2005; 365: 785–99.Google Scholar

Wang, A, Rana, S, Karumanchi, SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology 2009; 24: 147–58.Google Scholar

Ness, RB, Sibai, BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gyncol 2006; 195: 40–9.CrossRefGoogle ScholarPubMed

Sibai, BM. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia. Semin Perinatol 2011; 35: 292–6.CrossRefGoogle ScholarPubMed

Bombrys, AE, Barton, JR, Nowacki, EA, et al. Expectant management of severe pre-eclampsia at less than 27 weeks’ gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 2008; 199: 247.e1–6.Google Scholar

Sibai, BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 2004; 190: 1520–6.Google Scholar

Altman, D, Carroli, G, Duley, L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulfate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 1: 1877–90.Google Scholar

Resnik, R, Creasy, RK. Intrauterine growth restriction. In Creasy, RK, Resnik, R, Iams, JD, et al., eds., Maternal-Fetal Medicine: Principles and Practice, 7th edn. Philadelphia: Saunders, 2014: 743–55.Google Scholar

Friedman, SA, Schiff, E, Kao, L, et al. Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol 1995; 172: 1785–92.Google Scholar

Mendola, P, Mumford, SL, Mannisto, TI, et al. Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth. Epidemiology 2015; 26: 17–26.Google Scholar

Riaz, M, Porat, R, Brodsky, NL, et al. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study. J Perinatol 1998; 18: 449–54.Google Scholar

Greenberg, MB, Penn, AA, Whitaker, KR, et al. Effect of magnesium sulfate exposure on term neonates. J Perinatol 2013; 33: 188–93.Google Scholar

Rouse, D, Hirtz, DG, Thom, E, et al. A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359: 895–905.Google Scholar

Constantine, MM, Weiner, SJ. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 2009; 114: 354–64.Google Scholar

Duley, L, Meher, S, Jones, L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2013; 7: CD001449.Google Scholar

Cooper, WO, Hernandez-Diaz, S, Arbogast, PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443–51Google Scholar

Magee, LA, Cham, C, Waterman, EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327: 955–64.Google Scholar